Loading...
XASX
BUB
Market cap50mUSD
Jul 09, Last price  
0.08AUD
1D
0.00%
1Q
-22.86%
Name

Bubs Australia Ltd

Chart & Performance

D1W1MN
XASX:BUB chart
P/E
13.06
P/S
0.71
EPS
0.01
Div Yield, %
Shrs. gr., 5y
10.29%
Rev. gr., 5y
13.42%
Revenues
103m
+28.66%
14,7014252,162,5622,763,7495,4500535,6321,293,0781,134,0911,818,77023,0973,932,29816,906,25643,914,85354,644,95239,312,73889,297,32460,110,62779,703,759102,544,417
Net income
6m
P
-336,399-1,179,3741,028,1231,523,332-1,190,706-2,866,36050,688-498,290-855,157-1,532,434-514,491-5,059,242-64,658,941-35,509,236-7,771,138-74,737,920-11,377,544-108,352,842-20,989,0585,543,841
CFO
6m
P
-837,859-2,001,226772,102-729,07650,522-436,047-1,262,5191,082,072-827,175-304,576-264,358-2,096,293-12,774,552-17,158,367-21,917,078-22,630,258-9,373,837-46,493,236-26,327,7006,131,920

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bubs Australia Limited, along with its associated entities, specializes in the manufacturing and global distribution of a diverse range of infant nutrition products, catering to consumers in Australia, China, and other international markets. Operating under its primary 'Bubs' brand, the company's offerings span organic baby foods, goat milk and organic cow's milk formulas (including infant and supreme variants), adult goat milk powder, and fresh dairy items. The product portfolio further extends to convenient pouches, wholesome cereals and porridges, rusks, and various snacks. Beyond its core brands, Bubs Australia also provides children's vitamin and mineral supplements, branded as 'Vita Bubs'. It additionally offers specialized canning services for nutritional dairy goods and safeguards its proprietary intellectual property and trademarks. The company, established in 1993, has its principal office situated in Frenchs Forest, Australia.
IPO date
Oct 05, 1993
Employees
95
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT